Description
GLP-2 TZ is a dual-receptor research agonist targeting GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. The dual-agonist class has been characterized in the research literature for metabolic research, glucose-regulation research, and lipid-metabolism research. Nova supplies GLP-2 TZ across three lyophilized vial strengths: 10mg, 30mg, and 60mg in 3mL vials, and 100mg in a 10mL vial. All require reconstitution before research use. Every batch is triple-tested by an independent, ISO/IEC 17025-accredited laboratory. Every vial ships with a QR code linked to its batch Certificate of Analysis. For research use only. Not for human or animal consumption.
S***a P****r –
I have been tracking GLP-2 TZ in my research catalog for some time, and this purchase from Nova Rash exceeded my expectations. The product details clearly state it is a dual-receptor agonist targeting GLP-1 and GIP, which aligns perfectly with my lipid-metabolism research goals. I particularly appreciated the triple-testing by an independent, ISO/IEC 17025-accredited laboratory; seeing the QR code on the vial and verifying the batch Certificate of Analysis online provided excellent peace of mind regarding purity and accuracy. The lyophilized powder reconstituted smoothly, and the packaging information was clear and professional. Compared to other suppliers I have evaluated, Nova Rash offers a transparent and high-quality product that is well-suited for serious research applications. I am very pleased with this acquisition.